The etiology of urinary tract infection: Traditional and emerging pathogens

被引:308
作者
Ronald, A
机构
来源
DM DISEASE-A-MONTH | 2003年 / 49卷 / 02期
关键词
ESCHERICHIA-COLI STRAINS; DIABETIC-PATIENTS; RANDOMIZED TRIAL; WOMEN; ADULTS; RESISTANCE; VIRULENCE; PYELONEPHRITIS; CIPROFLOXACIN; COLONIZATION;
D O I
10.1067/mda.2003.8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The microbial etiology of urinary infections has been regarded as well established and reasonably consistent. Escherichia coli remains the predominant uropathogen (80%) isolated in acute community-acquired uncomplicated infections, followed by Staphylococcus saprophyticus (10% to 15%). Klebsiella, Enterobacter, and Proteus species, and enterococci infrequently cause uncomplicated cystitis and pyelonephritis. The pathogens traditionally associated with UTI are changing many of their features, particularly because of antimicrobial resistance. The etiology of UTI is also affected by underlying host factors that complicate UTI, such as age, diabetes, spinal cord injury, or catheterization. Consequently, complicated UTI has a more diverse etiology than uncomplicated UTI, and organisms that rarely cause disease in healthy patients can cause significant disease in hosts with anatomic, metabolic, or immunologic underlying disease. The majority of community-acquired symptomatic UTIs in elderly women are caused by E coli. However, gram-positive organisms are common, and polymicrobial infections account for up to I in 3 infections in the elderly. In comparison, the most common organisms isolated in children with uncomplicated UTI are Enterobacteriaceae. Etiologic pathogens associated with UTI among patients with diabetes include Klebsiella spp., Group B streptococci, and Enterococcus spp., as well as E coli. Patients with spinal cord injuries commonly have E coli infections. Other common uropathogens include Pseudomonas and Proteus mirabilis. Recent advances in molecular biology may facilitate the identification of new etiologic agents for UTI. The need for accurate and updated population surveillance data is apparent, particularly in light of concerns regarding antimicrobial resistance. This information will directly affect selection of empiric therapy for UTI.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 35 条
[1]   Management of urinary tract infections in the elderly [J].
Beyer, I ;
Mergam, A ;
Benoit, F ;
Theunissen, C ;
Pepersack, T .
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2001, 34 (02) :153-157
[2]   Urinary tract infection in diabetic patients [J].
Bonadio, M ;
Meini, M ;
Gigli, C ;
Longo, B ;
Vigna, A .
UROLOGIA INTERNATIONALIS, 1999, 63 (04) :215-219
[3]   P-FIMBRIATION AND HEMOLYSIN PRODUCTION ARE THE MOST IMPORTANT VIRULENCE FACTORS IN DIABETIC-PATIENTS WITH ESCHERICHIA-COLI BACTEREMIA - A MULTIVARIATE STATISTICAL-ANALYSIS OF 7 BACTERIAL VIRULENCE FACTORS [J].
BRAUNER, A ;
KATOULI, M ;
OSTENSON, CG .
JOURNAL OF INFECTION, 1995, 31 (01) :27-31
[4]   SECULAR TRENDS IN RATES AND ETIOLOGY OF NOSOCOMIAL URINARY-TRACT INFECTIONS AT A UNIVERSITY HOSPITAL [J].
BRONSEMA, DA ;
ADAMS, JR ;
PALLARES, R ;
WENZEL, RP .
JOURNAL OF UROLOGY, 1993, 150 (02) :414-416
[5]   Pathogenesis of Proteus mirabilis urinary tract infection [J].
Coker, C ;
Poore, CA ;
Li, X ;
Mobley, HLT .
MICROBES AND INFECTION, 2000, 2 (12) :1497-1505
[6]  
Foxman B, 2000, AM J EPIDEMIOL, V151, P1194, DOI 10.1093/oxfordjournals.aje.a010170
[7]   Binding of pill from uropathogenic Escherichia coli to membranes secreted by human colonocytes and enterocytes [J].
Goetz, GS ;
Mahmood, A ;
Hultgren, SJ ;
Engle, MJ ;
Dodson, K ;
Alpers, DH .
INFECTION AND IMMUNITY, 1999, 67 (11) :6161-6163
[8]   Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women [J].
Gupta, K ;
Scholes, U ;
Stamm, WE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (08) :736-738
[9]   THE EMERGENCE AND MECHANISMS OF TRIMETHOPRIM RESISTANCE IN ESCHERICHIA-COLI ISOLATED FROM OUTPATIENTS IN FINLAND [J].
HEIKKILA, E ;
RENKONEN, OV ;
SUNILA, R ;
UURASMAA, P ;
HUOVINEN, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) :275-283
[10]   Practice guidelines for urinary tract infection in the era of managed care [J].
Hooton, TM .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 11 (3-4) :241-245